Prices are updated after-hours


Sort by: gain open | gain high | gain close | publishing date

symbols : SRNE    save search

SORRENTO THERAPEUTICS ANNOUNCES COVISHIELD (STI-9167), A BROAD-SPECTRUM NEUTRALIZING ANTIBODY, POTENTLY NEUTRALIZES OMICRON AND OMICRON (+R346K) VARIANTS OF SARS-COV-2
Published: 2022-01-20 (Crawled : 19:00) - biospace.com/
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: 4.22% H: 0.0% C: 0.0%

sti-9167 ces era therapeutics sars-cov-2 antibody
Sorrento Announces That Sorrento Mexico Has Sold Out of One Million COVISTIX Tests Last Week in Mexico
Published: 2022-01-19 (Crawled : 21:00) - globenewswire.com
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: 4.22% H: 0.0% C: 0.0%

ces test
Sorrento Announces Completion of Enrollment in US Phase 2 Clinical Trial for COVI-DROPS and Achievement of Interim Analysis Threshold in the UK
Published: 2022-01-19 (Crawled : 17:00) - biospace.com/
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: -2.06% H: 0.0% C: 0.0%

phase 2 ces trial drop
Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Clinical Trial of COVI-MSC in COVID-19 Patients With Persistent Pulmonary Compromise After Recovery (Long-Hauler)
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: 2.35% H: 0.0% C: 0.0%

covid-19 health phase 2 trial covid brazil
Outlook on the CAR T-cell Therapy Global Market to 2031 - by Product Type, Indications, End-user and Region
Published: 2022-01-14 (Crawled : 14:00) - prnewswire.com
NVSEF | News | $88.6 | twitter stocktwits trandingview |
Health Technology
| | O: 1.26% H: 0.0% C: 0.0%
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: -5.96% H: 0.0% C: 0.0%
NVS | News | $88.91 | twitter stocktwits trandingview |
Health Technology
| | O: 0.02% H: 0.0% C: 0.0%
GILD | $67.81 | twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.0% C: 0.0%
BLUE | $6.93 | twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.0% C: 0.0%
JNJ | News | $167.27 | twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 0.0% C: 0.0%

era cel therapy t-cell
Sorrento Therapeutics Mexico Wins Tender to Sell COVISTIX Tests to Mexico City Government
Published: 2022-01-13 (Crawled : 15:30) - globenewswire.com
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: 0.89% H: 0.0% C: 0.0%

era therapeutics test
Dr. Henry Ji to Present at HC Wainwright BIOCONNECT Virtual Conference (January 10th – 13th)
Published: 2022-01-07 (Crawled : 17:00) - globenewswire.com
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: 0.66% H: 0.0% C: 0.0%

conference
Dr. Henry Ji to Participate in Longwood Healthcare Leaders Winter Webconference Panel on January 6th 2022
Published: 2022-01-04 (Crawled : 14:00) - globenewswire.com
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: 1.02% H: 0.81% C: -4.44%

health thc conference
WuXi Biologics and ImmuneOncia Sign MOU for Development and Manufacturing of Anti-PD-L1/CD47 Bispecific Antibody
Published: 2021-12-28 (Crawled : 01:00) - prnewswire.com
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: -1.26% H: 1.45% C: -10.73%

cd47 antibody
Sorrento Therapeutics Mexico Executes Second Contract for Sale of 10 Million COVISTIX Tests for Mexico Market
Published: 2021-12-27 (Crawled : 20:00) - biospace.com/
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: 2.78% H: 0.52% C: -5.42%

contract era therapeutics test
Sorrento Announces COVISTIX COVID-19 Virus Rapid Antigen Detection Test Detects the Omicron Variant
Published: 2021-12-27 (Crawled : 15:30) - globenewswire.com
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: 2.78% H: 0.52% C: -5.42%

covid-19 ces covid test
Sorrento Therapeutics Announces FDA Clearance of Its IND Application of Next Generation oHSV Oncolytic Virus STI-1386 for Patients With Relapsed and Refractory Solid Tumors
Published: 2021-12-20 (Crawled : 15:30) - biospace.com/
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: -1.46% H: 1.49% C: -2.34%

sti-1386 fda clearance solid tumors application ces era therapeutics fda clearance
Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Positive Top-Line Results from its Phase 3 Non-Opioid Injectable SP-102 (SEMDEXA™) Pivotal Trial
Published: 2021-12-09 (Crawled : 22:00) - biospace.com/
VCKA | $10.09 | twitter stocktwits trandingview |
| | O: -0.15% H: 0.25% C: 0.15%
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: 1.03% H: 2.75% C: -2.6%

sp-102 era trial therapeutics opioid positive results phase 3
Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Positive Top-Line Results from its Phase 3 Non-Opioid Injectable SP-102 (SEMDEXA™) Pivotal Trial C.L.E.A.R. Program for Sciatica Pain Management Supporting the Potential Use of SP-102 as a Best-in-Class Therapy
Published: 2021-12-09 (Crawled : 17:00) - globenewswire.com
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: 1.03% H: 2.75% C: -2.6%
VCKA | $10.09 | twitter stocktwits trandingview |
| | O: -0.15% H: 0.25% C: 0.15%

sp-102 era trial therapeutics potential opioid positive therapy results phase 3
Sorrento Therapeutics’ Clinical Laboratory Receives Accreditation From the College of American Pathologists
Published: 2021-12-07 (Crawled : 19:00) - globenewswire.com
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: 6.57% H: 14.77% C: 11.21%

era therapeutics
Sorrento Begins Enrollment in Phase 2 Trial of Resiniferatoxin (RTX) for the Treatment of Pain Due to Knee Osteoarthritis (OA)
Published: 2021-12-07 (Crawled : 19:00) - globenewswire.com
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: -1.68% H: 9.4% C: 7.52%

treatment phase 2 xin era osteoarthritis trial
Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
Published: 2021-12-07 (Crawled : 14:00) - prnewswire.com
RDHL | $2.9 | twitter stocktwits trandingview |
Health Technology
| | O: 0.37% H: 10.37% C: 9.63%
GLAXF | News | $22.8 | twitter stocktwits trandingview |
Health Technology
| | O: 5.22% H: 0.0% C: -1.25%
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: 6.57% H: 14.77% C: 11.21%
JNJ | News | $167.27 | twitter stocktwits trandingview |
Health Technology
| | O: 2.13% H: 0.0% C: 0.0%
GSK | News | $45.14 | twitter stocktwits trandingview |
Health Technology
| | O: 0.14% H: 0.0% C: 0.0%
VIR | $33.14 | twitter stocktwits trandingview |
Health Technology
| | O: -6.42% H: 8.6% C: 8.45%

covid vaccine
Sorrento Receives Orders of COVISTIX for Commercial Launch in Brazil
Published: 2021-12-06 (Crawled : 20:00) - globenewswire.com
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: 6.57% H: 14.77% C: 11.21%

order brazil
Sorrento Announces Publication of a Series of Novel SARS-CoV-2 Main Protease (MPRO) Inhibitors for Potential Treatment of COVID-19 Patients Infected With SARS-CoV-2 Variants Of Concern, Including Omicron
Published: 2021-12-05 (Crawled : 20:20) - globenewswire.com
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: -9.22% H: 0.0% C: 0.0%

treatment covid potential sars-cov-2
Dr. Henry Ji to Participate in the CEO Fireside Chat Evercore ISI 4th Annual HealthCONx Conference
Published: 2021-11-30 (Crawled : 14:00) - globenewswire.com
SRNE | $4.45 | twitter stocktwits trandingview |
Health Technology
| | O: -5.19% H: 0.0% C: 0.0%

ceo conference
Your saved searches


Save your searches and get alerts when important news are released.

Mentioned Today
COTY | News | $8.64 | twitter stocktwits trandingview |
Consumer Non-Durables

DXR | News | $11.16 | twitter stocktwits trandingview |
Health Technology

FCFS | News | $73.31 | twitter stocktwits trandingview |
Finance

INCY | News | $74.76 | twitter stocktwits trandingview |
Health Technology

KRP | News | $14.73 | twitter stocktwits trandingview |
Miscellaneous

LLY | News | $246.46 | twitter stocktwits trandingview |
Health Technology

OVLY | News | $17.6 | twitter stocktwits trandingview |
Finance